BRPI0714509A2 - Inibidores de transcriptase reversa de não-nucleosídeo. - Google Patents
Inibidores de transcriptase reversa de não-nucleosídeo.Info
- Publication number
- BRPI0714509A2 BRPI0714509A2 BRPI0714509-8A2A BRPI0714509A BRPI0714509A2 BR PI0714509 A2 BRPI0714509 A2 BR PI0714509A2 BR PI0714509 A BRPI0714509 A BR PI0714509A BR PI0714509 A2 BRPI0714509 A2 BR PI0714509A2
- Authority
- BR
- Brazil
- Prior art keywords
- reverse transcriptase
- transcriptase inhibitors
- nucleoside reverse
- nucleoside
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83248206P | 2006-07-21 | 2006-07-21 | |
| PCT/EP2007/057155 WO2008009613A1 (en) | 2006-07-21 | 2007-07-12 | Non-nucleoside reverse transcriptase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0714509A2 true BRPI0714509A2 (pt) | 2014-04-08 |
Family
ID=38521766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0714509-8A2A BRPI0714509A2 (pt) | 2006-07-21 | 2007-07-12 | Inibidores de transcriptase reversa de não-nucleosídeo. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080020981A1 (pt) |
| EP (1) | EP2046731A1 (pt) |
| JP (1) | JP2009544645A (pt) |
| KR (1) | KR20090031584A (pt) |
| CN (1) | CN101484418A (pt) |
| AR (1) | AR061943A1 (pt) |
| AU (1) | AU2007276180A1 (pt) |
| BR (1) | BRPI0714509A2 (pt) |
| CA (1) | CA2657723A1 (pt) |
| CL (1) | CL2007002105A1 (pt) |
| IL (1) | IL196144A0 (pt) |
| MX (1) | MX2009000574A (pt) |
| PE (1) | PE20080558A1 (pt) |
| TW (1) | TW200812942A (pt) |
| WO (1) | WO2008009613A1 (pt) |
| ZA (1) | ZA200900071B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1940781A1 (en) * | 2005-10-19 | 2008-07-09 | F.Hoffmann-La Roche Ag | Phenyl-acetamide nnrt inhibitors |
| MX2009013865A (es) * | 2007-06-22 | 2010-01-27 | Hoffmann La Roche | Urea y derivados carbamato como inhibidores no nucleosidicos de la transcriptasa inversa. |
| CN102229547A (zh) * | 2011-04-20 | 2011-11-02 | 复旦大学 | 一种萘苯醚类苯磺酰胺衍生物及其制备方法和用途 |
| CN102206177A (zh) * | 2011-04-20 | 2011-10-05 | 复旦大学 | 1-萘基苯甲酮衍生物及其制备方法和用途 |
| ES2895773T3 (es) * | 2016-05-12 | 2022-02-22 | Res Triangle Inst | Fenetilaminas vinílogas como liberadores de neurotransmisores |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003095463A1 (en) * | 2002-05-07 | 2003-11-20 | Akzo Nobel N.V. | Neopentylglycol bis (diarylphosphate) esters |
| TW200423930A (en) * | 2003-02-18 | 2004-11-16 | Hoffmann La Roche | Non-nucleoside reverse transcriptase inhibitors |
| CN100469769C (zh) * | 2003-03-24 | 2009-03-18 | 弗·哈夫曼-拉罗切有限公司 | 作为逆转录酶抑制剂的苄基-哒嗪酮 |
| TW200505441A (en) * | 2003-03-24 | 2005-02-16 | Hoffmann La Roche | Non-nucleoside reverse transcriptase inhibitorsⅠ |
| US7220772B2 (en) * | 2003-09-05 | 2007-05-22 | Pfizer, Inc. | Pyrazole derivatives |
| CA2559552A1 (en) * | 2004-03-23 | 2005-09-29 | F. Hoffmann-La Roche Ag | Benzyl-pyridazinone derivatives as non-nucleoside reverse transcriptase inhibitors |
| US7625949B2 (en) * | 2004-04-23 | 2009-12-01 | Roche Palo Alto Llc | Methods for treating retroviral infections |
| JP4675959B2 (ja) * | 2004-07-27 | 2011-04-27 | エフ．ホフマン−ラ ロシュ アーゲー | 非ヌクレオシド逆転写酵素阻害剤としてのベンジルトリアゾロン化合物 |
| WO2006034583A1 (en) * | 2004-09-30 | 2006-04-06 | Boehringer Ingelheim International Gmbh & Co Kg | Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors |
| EP1831157A2 (en) * | 2004-12-22 | 2007-09-12 | Pfizer Limited | Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| CA2600759A1 (en) * | 2005-03-24 | 2006-09-28 | F. Hoffmann-La Roche Ag | 1,2,4-triazole-5-one compounds as heterocyclic reverse transcriptase inhibitors |
| AR057455A1 (es) * | 2005-07-22 | 2007-12-05 | Merck & Co Inc | Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica |
| JP2009510013A (ja) * | 2005-09-30 | 2009-03-12 | エフ．ホフマン−ラ ロシュ アーゲー | Ｎｎｒｔ阻害剤 |
| ES2320042T3 (es) * | 2005-10-19 | 2009-05-18 | F. Hoffmann-La Roche Ag | Inhibidores de transcriptasa reversa con nucleosidos de n-fenil fenilacetamida. |
| EP1940781A1 (en) * | 2005-10-19 | 2008-07-09 | F.Hoffmann-La Roche Ag | Phenyl-acetamide nnrt inhibitors |
-
2007
- 2007-07-10 CL CL200702105A patent/CL2007002105A1/es unknown
- 2007-07-12 JP JP2009521203A patent/JP2009544645A/ja active Pending
- 2007-07-12 BR BRPI0714509-8A2A patent/BRPI0714509A2/pt not_active IP Right Cessation
- 2007-07-12 EP EP07787426A patent/EP2046731A1/en not_active Withdrawn
- 2007-07-12 KR KR1020097001227A patent/KR20090031584A/ko not_active Application Discontinuation
- 2007-07-12 MX MX2009000574A patent/MX2009000574A/es not_active Application Discontinuation
- 2007-07-12 WO PCT/EP2007/057155 patent/WO2008009613A1/en active Application Filing
- 2007-07-12 CN CNA200780025636XA patent/CN101484418A/zh active Pending
- 2007-07-12 CA CA002657723A patent/CA2657723A1/en not_active Abandoned
- 2007-07-12 AU AU2007276180A patent/AU2007276180A1/en not_active Abandoned
- 2007-07-18 TW TW096126195A patent/TW200812942A/zh unknown
- 2007-07-19 PE PE2007000940A patent/PE20080558A1/es not_active Application Discontinuation
- 2007-07-20 AR ARP070103236A patent/AR061943A1/es unknown
- 2007-07-20 US US11/880,229 patent/US20080020981A1/en not_active Abandoned
-
2008
- 2008-12-23 IL IL196144A patent/IL196144A0/en unknown
-
2009
- 2009-01-05 ZA ZA200900071A patent/ZA200900071B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2657723A1 (en) | 2008-01-24 |
| IL196144A0 (en) | 2009-09-22 |
| ZA200900071B (en) | 2010-01-27 |
| AR061943A1 (es) | 2008-10-01 |
| JP2009544645A (ja) | 2009-12-17 |
| CN101484418A (zh) | 2009-07-15 |
| AU2007276180A1 (en) | 2008-01-24 |
| KR20090031584A (ko) | 2009-03-26 |
| WO2008009613A1 (en) | 2008-01-24 |
| EP2046731A1 (en) | 2009-04-15 |
| PE20080558A1 (es) | 2008-05-16 |
| CL2007002105A1 (es) | 2008-02-22 |
| US20080020981A1 (en) | 2008-01-24 |
| MX2009000574A (es) | 2009-01-27 |
| TW200812942A (en) | 2008-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0715193A2 (pt) | inibidores nço-nucleosÍdicos da transcriptase reversa | |
| BRPI0813269A2 (pt) | Inibidores de hiv transcriptase reversa | |
| ZA200903395B (en) | Non-nucleoside reverse transcriptase inhibitors | |
| NO20161397A1 (no) | Ikke-nukleosidbaserte revers-transkriptase-inhibitorer | |
| EP2076492A4 (en) | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | |
| EP2217069A4 (en) | INHIBITORS OF NON-NUCLEOSIDE INHIBITORS OF THE REVERSE TRANSCRIPTASE | |
| IL205386A0 (en) | Non - nucleoside reverse transcriptase inhibitors | |
| ATE425138T1 (de) | N-phenyl-phenylacetamid-nichtnukleosidinhibitor n reverser transkriptase | |
| FR2909857B1 (fr) | Endovalve. | |
| DK2086939T3 (da) | Pyridiacarboxamid som II-beta-HSDI-inhibitorer | |
| DK2383271T3 (da) | Aminoquinoloner som GSK-3-inhibitorer | |
| EP2220091A4 (en) | REVERSE transcriptase inhibitors | |
| BRPI0810496A2 (pt) | inibidores de transcriptase reversa de não-nucleosídeo | |
| BRPI0714509A2 (pt) | Inibidores de transcriptase reversa de não-nucleosídeo. | |
| EP1899340A4 (en) | NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS | |
| BRPI0811645A2 (pt) | Inibidores de transcriptase reversa de não-nucleosídeo | |
| NL1033745A1 (nl) | Sleepboot. | |
| FR2905588B1 (fr) | Agrafe chirurgicale. | |
| ITCE20060002A1 (it) | Patok. | |
| ES1061980Y (es) | Contenedor-palet. | |
| ES1062074Y (es) | Autorefrigerante solar-ecologico. | |
| FI20070109A0 (fi) | WC-istuin-pisuaari-yhdistelmä | |
| ITSS20060011A1 (it) | Posablocchi. | |
| ITAV20060001A1 (it) | Generafiume. | |
| ITPA20060014A1 (it) | Rubino - macrotex. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 4A, 5A, 6A E 7A ANUIDADES. |
|
| B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A, 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |